Mark Bodmer

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Marella Thorell, Attorney-in-Fact for Mark Bodmer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Bodmer:

Company Role Class Num Shares Value Price $ Report Date Ownership
Evelo Biosciences, Inc. CSO, President of R&D Common Stock 25,732 $8,492 $0.3300 08 Nov 2023 Direct
Evelo Biosciences, Inc. CSO, President of R&D Restricted Stock Units 6,625 07 Nov 2023 Direct

Insider Reports Filed by Mark Bodmer

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000169466523000179-bodmer-mark-2023-11-07 Evelo Biosciences, Inc. 07 Nov 2023 3 -$1,044 4 CSO, President of R&D 08 Nov 2023, 20:32
/report/000169466523000169-bodmer-mark-2023-11-01 Evelo Biosciences, Inc. 01 Nov 2023 3 -$2,262 4 CSO, President of R&D 03 Nov 2023, 16:12
/report/000169466523000156-bodmer-mark-2023-09-11 Evelo Biosciences, Inc. 11 Sep 2023 1 $0 4 CSO, President of R&D 13 Sep 2023, 20:55
/report/000169466523000136-bodmer-mark-2023-08-07 Evelo Biosciences, Inc. 07 Aug 2023 3 -$29,747 4 CSO, President of R&D 09 Aug 2023, 20:44
/report/000169466523000080-bodmer-mark-2023-05-23 Evelo Biosciences, Inc. 23 May 2023 1 -$3,201 4 CSO, President of R&D 12 Jun 2023, 16:01
/report/000169466523000053-bodmer-mark-2023-05-08 Evelo Biosciences, Inc. 08 May 2023 1 -$8,536 4 CSO, President of R&D 10 May 2023, 21:31
/report/000169466523000042-bodmer-mark-2023-05-07 Evelo Biosciences, Inc. 07 May 2023 2 $0 4 CSO, President of R&D 09 May 2023, 16:08
/report/000169466523000013-bodmer-mark-2023-02-07 Evelo Biosciences, Inc. 07 Feb 2023 1 $0 4 CSO, President of R&D 09 Feb 2023, 15:32
/report/000169466522000015-bodmer-mark-2022-01-19 Evelo Biosciences, Inc. 19 Jan 2022 1 $0 4 CSO, President of R&D 21 Jan 2022, 15:50